Ulf Simonsen Selected Research

BW A868C

8/2015

Hypoxia-induced relaxation of porcine retinal arterioles in vitro depends on inducible NO synthase and EP4 receptor stimulation in the perivascular retina.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulf Simonsen Research Topics

Disease

27	Hypoxia (Hypoxemia) 01/2022 - 01/2003
18	Hypertension (High Blood Pressure) 07/2020 - 08/2002
13	Pulmonary Hypertension 01/2021 - 01/2004
7	Erectile Dysfunction 01/2022 - 07/2002
6	Heart Failure 04/2022 - 05/2011
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 05/2009
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2009
5	Right Ventricular Hypertrophy 01/2021 - 01/2004
5	Pulmonary Arterial Hypertension 10/2018 - 01/2017
4	Fibrosis (Cirrhosis) 01/2021 - 01/2017
4	Neoplasms (Cancer) 12/2020 - 04/2010
3	Necrosis 01/2022 - 04/2010
3	Pulmonary Alveolar Microlithiasis 01/2022 - 09/2012
3	Lung Diseases (Lung Disease) 01/2022 - 09/2012
3	Vascular Remodeling 01/2021 - 08/2008
3	Atherosclerosis 01/2016 - 05/2009
3	Glaucoma 09/2013 - 12/2012
3	Myocardial Infarction 05/2012 - 12/2007
3	Renovascular Hypertension (Goldblatt Syndrome) 07/2007 - 08/2002
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 04/2021
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2021
2	Lung Injury 01/2022 - 04/2021
2	Pulmonary Edema 01/2022 - 01/2004
2	COVID-19 01/2022 - 01/2020
2	Heart Arrest (Cardiac Arrest) 10/2021 - 06/2021
2	Hypertrophy 01/2021 - 08/2008
2	Soft Tissue Infections 01/2018 - 05/2015
2	Sepsis (Septicemia) 01/2018 - 01/2017
2	Retinal Diseases 11/2017 - 11/2015
2	Nausea 01/2017 - 10/2016
2	Infarction (Infarctions) 04/2016 - 12/2007
2	Obesity 05/2014 - 05/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2013 - 08/2012
2	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2012 - 07/2012
2	Idiopathic Pulmonary Fibrosis 07/2012 - 06/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2012 - 09/2008
2	Vascular Diseases (Vascular Disease) 03/2011 - 08/2009

Drug/Important Bio-Agent (IBA)

15	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 08/2002
10	Pharmaceutical PreparationsIBA 04/2022 - 05/2009
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2007
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2008
6	Vasodilator Agents (Vasodilators)IBA 01/2018 - 07/2002
6	Oxygen (Dioxygen)IBA 08/2017 - 01/2004
6	Nitric Oxide Synthase (NO Synthase)IBA 08/2015 - 07/2007
5	Arginine (L-Arginine)FDA Link 01/2018 - 01/2006
5	Glucose (Dextrose)FDA LinkGeneric 05/2014 - 08/2004
4	sacubitril and valsartan sodium hydrate drug combinationIBA 04/2022 - 01/2016
4	PotassiumIBA 01/2022 - 08/2004
4	senicapocIBA 01/2022 - 04/2021
4	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2022 - 07/2007
4	CalciumIBA 01/2022 - 09/2015
4	Sildenafil Citrate (Viagra)FDA Link 01/2021 - 03/2005
4	Phosphodiesterase 5 InhibitorsIBA 01/2019 - 03/2005
4	Retinaldehyde (Retinal)IBA 11/2017 - 08/2009
3	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2022 - 08/2010
3	SodiumIBA 01/2022 - 05/2014
3	Carrier Proteins (Binding Protein)IBA 01/2022 - 12/2011
3	EnzymesIBA 01/2021 - 12/2009
3	ReninIBA 01/2020 - 08/2002
3	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2018 - 09/2008
3	Angiotensin Receptor AntagonistsIBA 10/2017 - 01/2009
3	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 05/2012 - 08/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2011 - 01/2009
3	Endothelin-1 (Endothelin 1)IBA 05/2011 - 01/2003
3	tempolIBA 05/2009 - 01/2004
2	Phosphates (Orthophosphate)IBA 01/2022 - 01/2020
2	CytokinesIBA 01/2022 - 04/2021
2	ApaminIBA 01/2022 - 01/2014
2	salicylhydroxamic acid (SHAM)IBA 10/2021 - 01/2011
2	Interleukin-6 (Interleukin 6)IBA 04/2021 - 01/2017
2	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2021 - 01/2021
2	Vasopressins (Vasopressin)IBA 01/2020 - 01/2003
2	macitentanIBA 10/2018 - 08/2018
2	selexipagIBA 10/2018 - 01/2017
2	NitritesIBA 01/2018 - 06/2007
2	Valsartan (Vals)FDA Link 01/2018 - 01/2016
2	sacubitrilIBA 01/2018 - 01/2016
2	Adrenergic Receptors (Adrenergic Receptor)IBA 08/2017 - 05/2012
2	Vasoconstrictor AgentsIBA 01/2017 - 05/2011
2	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 05/2008
2	Apolipoproteins E (ApoE)IBA 01/2016 - 11/2011
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2016 - 01/2009
2	Endothelins (Endothelin)IBA 11/2015 - 10/2005
2	Peptides (Polypeptides)IBA 01/2015 - 02/2009
2	Potassium Channels (Potassium Channel)IBA 05/2014 - 05/2011
2	Nebivolol FDA Link 05/2014 - 05/2012
2	KATP ChannelsIBA 05/2014 - 02/2009
2	Adenosine (Adenocard)FDA LinkGeneric 01/2014 - 01/2006
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2013 - 07/2010
2	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 09/2013 - 02/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 03/2011
2	Actins (F Actin)IBA 12/2011 - 11/2007
2	Soluble Guanylyl CyclaseIBA 11/2010 - 06/2007
2	Drinking WaterIBA 11/2010 - 01/2004
2	Phosphotransferases (Kinase)IBA 06/2010 - 11/2007

Therapy/Procedure

7	Therapeutics 04/2022 - 03/2011
2	Resuscitation 10/2021 - 06/2021
2	Endarterectomy (Thromboendarterectomy) 01/2019 - 01/2017
2	Surgical Amputation (Amputations) 01/2018 - 05/2015
2	Hyperbaric Oxygenation 01/2017 - 05/2015